GLP‑1, GIP and peptide therapies are available now

Prescriptions filled through state‑licensed, FDA‑registered pharmacies. Read the facts

Success Weightloss Systems Inc.

Disclaimer

The fine print, in plain sight.

You should understand anything you introduce to your body.

What the FDA requires us to say, what we say ourselves, and where we stand. Read it before you decide, and bring your questions to the free consultation.

Required by the FDA

The HCG statement

The FDA requires this disclaimer regarding HCG. We print it in full.

HCG has not been demonstrated to be effective adjunctive therapy in the treatment of obesity. There is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction, that it causes a more attractive or “normal” distribution of fat, or that it decreases the hunger and discomfort associated with calorie‑restricted diets.

Medical disclaimer

What this website is, and isn’t

Prescriptions

Semaglutide, tirzepatide, Ozempic, Rybelsus, Wegovy, Mounjaro, Zepbound and HCG are prescription medications and are available only with a prescription from a licensed provider.

Compounding

Compounded medications are not FDA‑approved, and the FDA does not verify their safety or effectiveness. Ours are filled through state‑licensed pharmacies.

Results

Client results shared on this website are individual experiences and are not a guarantee of results. Individual results vary.

Not medical advice

This website is for information only and is not medical advice. Talk with your healthcare provider about any medication you are considering.

Where we stand

Our perspective

An ounce of prevention is worth a pound of cure.

The opinions in this section are those of Success Weightloss Systems.

Hundreds of our clients, and hundreds of thousands of die‑hard HCG participants around the globe, respectfully disagree with the statement above. Obesity is the largest single preventable health epidemic facing America. It has been clearly linked to diabetes, cancer and coronary disease. To us, treating obesity, and reducing the occurrence of the chronic illnesses directly linked to it, makes more sense than treating the chronic illness after the fact. At Success Weightloss Systems we believe an ounce of prevention is worth a pound of cure.

We often question the viability and safety of the countless diet drugs that were fast‑tracked by the FDA. Years later, drugs like Fen‑Phen were clearly linked to extensive heart damage, and others to kidney, liver and heart damage. Current information in the healthcare database of the province of Ontario indicates that patients who take Orlistat are at greater risk of liver and kidney damage. Orlistat is the active ingredient in the diet drugs Xenical and Alli.

For the record

A note on FDA history

Background every parent should read, as published on our original website.

A study conducted by the U.S. Congress in 1969 revealed that 37 of 49 top officials who left the FDA moved into high‑profile corporate positions with the large companies they had been regulating. A General Accounting Office (GAO) study of the FDA in 1975 revealed that 150 FDA officials owned stock in the companies they were supposed to regulate. These arrangements could explain why the FDA removed Renee Dufault from the majority of her field work after she discovered mercury in high‑fructose corn syrup.

A report by the Edmonds Institute includes the names of numerous individuals who move in and out of key positions with the FDA and the very companies they are supposed to regulate. One example: in order for the FDA to determine whether Monsanto’s growth hormones were safe, Monsanto was required to submit a scientific report on the topic. Margaret Miller, one of Monsanto’s researchers, put the report together. Shortly before the report was submitted, Miller left Monsanto and was hired by the FDA. Her first job for the FDA was to determine whether or not to approve the report she had written for Monsanto. In short, Monsanto approved its own report.

Assisting Miller was another former Monsanto researcher, Susan Sechen. Deciding whether rBGH‑derived milk should be labeled fell under the jurisdiction of another FDA official, Michael Taylor, who previously worked as a lawyer for Monsanto and served as a top executive, lawyer and lobbyist for the company. In an earlier stint with the FDA, Taylor helped write the rules that allowed bovine growth hormone into the American food system and our children’s milk. This conflict of interest has been going on for decades.

Free consultation

Questions about any of this? Ask us. That’s the job.

A licensed provider reviews your history and medications before anything is prescribed.